Study List:
Étude 1:
Titre: Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Thyroid Cancer|Thyroid Disease
Interventions:
URL: http://ClinicalTrials.gov/show/NCT00341094
Étude 2:
Titre: Methadone Maintenance & HIV Risk in Ukraine
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Opioid Dependence
Interventions: Drug: Methadone
URL: http://ClinicalTrials.gov/show/NCT00351026
Étude 3:
Titre: Peer Leaders as HIV Risk Reduction Change Agents Among Injection Drug Users (IDUs) in Ukraine
Recruitment: Not yet recruiting
Study Results: No Results Available
Conditions: HIV Infections|Intervention
Interventions: Behavioral: Peer Education Model|Behavioral: HIV Counseling and Education Model
URL: http://ClinicalTrials.gov/show/NCT01159704
Étude 4:
Titre: Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident
Recruitment: Completed
Study Results: No Results Available
Conditions: Leukemia
Interventions: Behavioral: Occupational Radiation Safety Standards
URL: http://ClinicalTrials.gov/show/NCT00341016
Étude 5:
Titre: Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, Tracheobronchitis and Bronchitis, Acute Exacerbation of Chronic Bronchitis and Mild Community-acquired Pneumonia in Common Clinical Practice in Ukraine
Recruitment: Completed
Study Results: Has Results
Conditions: Respiratory Tract Infections
Interventions: Drug: Clarithromycin (Klacid SR)
URL: http://ClinicalTrials.gov/show/NCT01095978
Étude 6:
Titre: Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Studyy
Recruitment: Completed
Study Results: No Results Available
Conditions: Thyroid Cancer
Interventions:
URL: http://ClinicalTrials.gov/show/NCT01265381
Étude 7:
Titre: Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
Recruitment: Completed
Study Results: No Results Available
Conditions: Advanced Prostate Cancer|Lower Urinary Tract Symptoms
Interventions: Drug: Leuprolide acetate Depot Susp. 11,25 mg (Pologne), 3,75 mg (Ukraine)
URL: http://ClinicalTrials.gov/show/NCT01078545
Étude 8:
Titre: International Cooperation for Post-Cherynobyl NIS Thyroid Tissue and Data Banks
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Environment
Interventions:
URL: http://ClinicalTrials.gov/show/NCT00339274
Étude 9:
Titre: Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Required General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on Cardiovascular System in Common Clinical Practice
Recruitment: Recruiting
Study Results: No Results Available
Conditions: General Surgery
Interventions: Drug: sevoflurane
URL: http://ClinicalTrials.gov/show/NCT01282086
Étude 10:
Titre: Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV
Recruitment: Enrolling by invitation
Study Results: No Results Available
Conditions: TB|HIV
Interventions: Dietary Supplement: Immunoxel|Drug: Placebo|Drug: TB drugs+ Immunoxel|Drug: ATT+Placebo|Drug: ATT + Placebo|Drug: drug-resistant TB on ATT+Immunoxel|Drug: Immunoxel
URL: http://ClinicalTrials.gov/show/NCT01061593
Étude 11:
Titre: Phase II Trial Comparing ABI-007 to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Metastatic Breast Cancer
Interventions: Drug: Araxane versus Taxotere
URL: http://ClinicalTrials.gov/show/NCT00274456
Étude 12:
Titre: Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma
Recruitment: Completed
Study Results: No Results Available
Conditions: Bronchial Asthma
Interventions: Drug: salbutamol 100 mcg|Drug: BDP/salbutamol HFA pMDI|Drug: BDP/salbutamol CFC pMDI
URL: http://ClinicalTrials.gov/show/NCT00528723
Étude 13:
Titre: Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
Recruitment: Completed
Study Results: Has Results
Conditions: Bacterial Infections|Diabetic Foot|Osteomyelitis
Interventions: Drug: Tigecycline|Drug: Ertapenem
URL: http://ClinicalTrials.gov/show/NCT00366249
Étude 14:
Titre: Study Evaluating PPM-204 In Subjects With Type 2 Diabète
Recruitment: Terminated
Study Results: No Results Available
Conditions: Diabetes Mellitus
Interventions: Drug: PPM-204
URL: http://ClinicalTrials.gov/show/NCT00425919
Étude 15:
Titre: Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause
Recruitment: Completed
Study Results: No Results Available
Conditions: Menopause
Interventions: Drug: DVS-233
URL: http://ClinicalTrials.gov/show/NCT00195546
Étude 16:
Titre: Tuberculosis (TB) Immunotherapy Phase 2 Étude
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Tuberculosis
Interventions: Biological: V7|Other: placebo
URL: http://ClinicalTrials.gov/show/NCT01380119
Étude 17:
Titre: Russian Labor Migrant HIV Prevention Trial
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: HIV
Interventions: Behavioral: Social Network Intervention
URL: http://ClinicalTrials.gov/show/NCT01177995
Étude 18:
Titre: Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC
Recruitment: Not yet recruiting
Study Results: No Results Available
Conditions: Metastatic Colorectal Cancer
Interventions: Drug: Irintoecan|Drug: HA-Irinotecan solution for Infusion
URL: http://ClinicalTrials.gov/show/NCT01290783
Étude 19:
Titre: Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Sclérose en plaques
Interventions: Drug: Teriflunomide (HMR1726)|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT00622700
Étude 20:
Titre: Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Recruitment: Completed
Study Results: Has Results
Conditions: Atrial Fibrillation|Accident vasculaire cérébral
Interventions: Drug: warfarin|Drug: Dabigatran dose 1|Drug: Dabigatran dose 2
URL: http://ClinicalTrials.gov/show/NCT00262600
Étude 21:
Titre: 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Pulmonary Disease, Chronic Obstructive|Bronchite Chronique|Emphysema
Interventions: Drug: GSK573719/GW642444 125/25|Drug: GSK573719/GW642444 62.5/25|Drug: GW642444|Drug: tiotropium bromide
URL: http://ClinicalTrials.gov/show/NCT01316900
Étude 22:
Titre: Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Venous Thrombosis
Interventions: Drug: Enoxaparin|Drug: warfarin|Drug: Placebo for apixaban|Drug: Placebo for enoxaparin|Drug: Placebo for warfarin|Drug: apixaban
URL: http://ClinicalTrials.gov/show/NCT00643201
Étude 23:
Titre: LOGiC – Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Recruitment: Recruiting
Study Results: No Results Available
Conditions: or Gastro-esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.|ErbB2 (HER2) Amplified Gastric|Neoplasms, Gastrointestinal Tract|Esophageal
Interventions: Drug: Lapatinib|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT00680901
Étude 24:
Titre: A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Major Depressive Disorder
Interventions: Drug: LY2216684|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT01173601
Étude 25:
Titre: Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
Recruitment: Completed
Study Results: Has Results
Conditions: Arthrose|Arthrite, Rheumatoid
Interventions: Drug: Celecoxib|Drug: Diclofenac + Omeprazole
URL: http://ClinicalTrials.gov/show/NCT00141102
Étude 26:
Titre: Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
Recruitment: Completed
Study Results: No Results Available
Conditions: Venous Thrombosis|Pulmonary Embolism
Interventions: Drug: Apixaban|Drug: Enoxaparin
URL: http://ClinicalTrials.gov/show/NCT00457002
Étude 27:
Titre: EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Rheumatoid Arthritis|Psoriatic Arthritis|Ankylosing Spondylitis
Interventions:
URL: http://ClinicalTrials.gov/show/NCT01078402
Étude 28:
Titre: The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: CV Risk|Atherosclerosis|Maladie cardiovasculaire|Coronary Heart Disease
Interventions: Drug: Darapladib|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT00799903
Étude 29:
Titre: Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
Recruitment: Completed
Study Results: Has Results
Conditions: Bacterial Pneumonia
Interventions: Drug: Ceftaroline fosamil for Injection|Drug: IV Ceftriaxone|Drug: Placebo|Drug: Clarithromycin
URL: http://ClinicalTrials.gov/show/NCT00621504
Étude 30:
Titre: A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabète.
Recruitment: Completed
Study Results: No Results Available
Conditions: Diabetes Mellitus, Type 2
Interventions: Drug: aleglitazar|Drug: Actos
URL: http://ClinicalTrials.gov/show/NCT00461006
Étude 31:
Titre: Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia
Recruitment: Completed
Study Results: No Results Available
Conditions: Schizophrenia
Interventions: Drug: Placebo|Drug: RGH-188|Drug: RGH-188|Drug: RGH-188|Drug: Risperidone
URL: http://ClinicalTrials.gov/show/NCT00694707
Étude 32:
Titre: Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Diabetes Mellitus, Type 2|Acute Coronary Syndrome
Interventions: Drug: Alogliptin|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT00968708
Étude 33:
Titre: Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Metastatic Colorectal Cancer
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006) + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)|Drug: Matching placebo + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)
URL: http://ClinicalTrials.gov/show/NCT00865709
Étude 34:
Titre: Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
Recruitment: Completed
Study Results: No Results Available
Conditions: Refractory Partial Seizures
Interventions: Drug: perampanel|Drug: perampanel|Drug: perampanel|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT00700310
Étude 35:
Titre: BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Sclérose en plaques
Interventions: Drug: laquinimod|Drug: placebo|Drug: Interferon β-1a (Avonex®)
URL: http://ClinicalTrials.gov/show/NCT00605215
Étude 36:
Titre: Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Arthrite, Rheumatoid|Arthrose
Interventions: Drug: celecoxib|Drug: Ibuprofen|Drug: Naproxen
URL: http://ClinicalTrials.gov/show/NCT00346216
Étude 37:
Titre: Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Recruitment: Terminated
Study Results: No Results Available
Conditions: Atrial Fibrillation
Interventions: Drug: SSR126517E « biotinylated idraparinux »|Drug: warfarin
URL: http://ClinicalTrials.gov/show/NCT00580216
Étude 38:
Titre: A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005
Recruitment: Completed
Study Results: No Results Available
Conditions: Asthma
Interventions: Drug: SKP FlutiForm HFA pMDI
URL: http://ClinicalTrials.gov/show/NCT00747318
Étude 39:
Titre: A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis
Recruitment: Enrolling by invitation
Study Results: No Results Available
Conditions: Relapsing Multiple Sclerosis
Interventions: Drug: Laquinimod
URL: http://ClinicalTrials.gov/show/NCT01047319
Étude 40:
Titre: Safety and Efficacy Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Sclérose en plaques, Relapsing-remitting
Interventions: Drug: daclizumab HYP|Other: placebo
URL: http://ClinicalTrials.gov/show/NCT00390221
Étude 41:
Titre: A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Glatiramer acetate (GA)|Other: Placebo
URL: http://ClinicalTrials.gov/show/NCT01067521
Étude 42:
Titre: TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
Recruitment: Completed
Study Results: No Results Available
Conditions: Skin and Subcutaneous Tissue Bacterial Infections
Interventions: Drug: TR-701 FA|Drug: Linezolid
URL: http://ClinicalTrials.gov/show/NCT01170221
Étude 43:
Titre: Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects
Recruitment: Completed
Study Results: No Results Available
Conditions: Atrial Fibrillation|Atrial Flutter
Interventions: Drug: Tedisamil sesquifumarate
URL: http://ClinicalTrials.gov/show/NCT00126022
Étude 44:
Titre: Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms
Recruitment: Completed
Study Results: No Results Available
Conditions: Bronchial Asthma
Interventions: Drug: Beclomethasone dipropionate|Drug: Beclomethasone dipropionate/Salbutamol combination|Drug: Salbutamol
URL: http://ClinicalTrials.gov/show/NCT00497523
Étude 45:
Titre: GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Tumor Antigen-positive Non-Small Cell Lung Cancer|Lung Cancer, Non-Small Cell
Interventions: Biological: GSK1572932A Antigen-Specific Cancer Immunotherapeutic|Biological: Placebo Control
URL: http://ClinicalTrials.gov/show/NCT00480025
Étude 46:
Titre: A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults
Recruitment: Completed
Study Results: No Results Available
Conditions: Asthma
Interventions: Drug: FlutiForm 250/10|Drug: SKP-Fluticasone|Drug: Flovent Fluticasone HFA
URL: http://ClinicalTrials.gov/show/NCT00649025
Étude 47:
Titre: FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes
Recruitment: Completed
Study Results: No Results Available
Conditions: Acute Coronary Syndrome
Interventions: Drug: Varespladib Methyl (A-002)
URL: http://ClinicalTrials.gov/show/NCT00743925
Étude 48:
Titre: A Double-blind, Placebo-controlled, 2-year Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer’s Disease.
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Alzheimer Disease|Dementia, Alzheimer Type
Interventions: Drug: Galantamine|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT00679627
Étude 49:
Titre: The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Atherosclerosis|Acute Coronary Syndrome|Maladie cardiovasculaire|Coronary Heart Disease
Interventions: Drug: Darapladib 160 mg|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT01000727
Étude 50:
Titre: Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Adolescent Schizophrenia|Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Interventions: Drug: Aripiprazole
URL: http://ClinicalTrials.gov/show/NCT01122927
Étude 51:
Titre: PALMFlexS: Paliperidone Palmitate Flexible Dosing in Schizophrenia
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Schizophrenia
Interventions: Drug: Paliperidone Palmitate
URL: http://ClinicalTrials.gov/show/NCT01281527
Étude 52:
Titre: MICHELANGELO OASIS-6 : Fondaparinux in ST Elevation Myocardial Infarction
Recruitment: Completed
Study Results: No Results Available
Conditions: Myocardial Infarction|ST-elevation Myocardial Infarction|Acute Coronary Syndrome|Acute Myocardial Infarction
Interventions: Drug: Fondaparinux – UFH indicated|Other: Control – UFH not indicated|Drug: fondaparinux – UFH not indicated|Drug: Control – UFH
URL: http://ClinicalTrials.gov/show/NCT00064428
Étude 53:
Titre: Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes
Recruitment: Completed
Study Results: No Results Available
Conditions: Dyslipidemia/Glucose Metabolism Disorder
Interventions: Drug: fenofibrate and metformin combination (drug)
URL: http://ClinicalTrials.gov/show/NCT00349128
Étude 54:
Titre: A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation
Recruitment: Completed
Study Results: No Results Available
Conditions: Atrial Fibrillation
Interventions: Drug: YM150|Drug: Warfarin
URL: http://ClinicalTrials.gov/show/NCT00938730
Étude 55:
Titre: Study of Paclitaxel in Patients With Ovarian Cancer
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer
Interventions: Drug: Paclical®|Drug: Taxol®
URL: http://ClinicalTrials.gov/show/NCT00989131
Étude 56:
Titre: Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin
Recruitment: Completed
Study Results: No Results Available
Conditions: Hyperlipidemia
Interventions: Drug: fenofibrate / simvastatin|Drug: Atorvastatin
URL: http://ClinicalTrials.gov/show/NCT00362934
Étude 57:
Titre: Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
Recruitment: Completed
Study Results: No Results Available
Conditions: Atrial Fibrillation
Interventions: Drug: Placebo|Drug: Vernakalant (oral)
URL: http://ClinicalTrials.gov/show/NCT00526136
Étude 58:
Titre: Safety of Inhaled Insulin With Type 1 and Type 2 Diabète
Recruitment: Completed
Study Results: No Results Available
Conditions: Diabète, Type I|Diabetes Type 2
Interventions: Drug: Technosphere Insulin|Drug: Usual Care|Other: No Intervention
URL: http://ClinicalTrials.gov/show/NCT00308737
Étude 59:
Titre: Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
Recruitment: Completed
Study Results: No Results Available
Conditions: Asthma
Interventions: Drug: Beclomethasone plus formoterol fixed combination|Drug: Fluticasone plus salmeterol fixed combination
URL: http://ClinicalTrials.gov/show/NCT00497237
Étude 60:
Titre: Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium 2.5 mcg|Drug: tiotropium 5 mcg|Drug: Tiotropium 18 mcg
URL: http://ClinicalTrials.gov/show/NCT01126437
Étude 61:
Titre: Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension
Recruitment: Completed
Study Results: Has Results
Conditions: Essential Hypertension
Interventions: Drug: Olmesartan medoxomil 40 mg – Amlodipine 10 mg|Drug: Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 12.5mg|Drug: Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 25mg|Drug: OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg|Drug: OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg|Drug: OLM 40mg-AML 10mg-Hydrochlorothiazide 25mg
URL: http://ClinicalTrials.gov/show/NCT00902538
Étude 62:
Titre: Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Type 2 Diabetes Mellitus
Interventions: Drug: Exenatide Once Weekly|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT01144338
Étude 63:
Titre: Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
Recruitment: Completed
Study Results: No Results Available
Conditions: Asthma
Interventions: Drug: Fluticasone furoate/Vilanterol Inhalation Powder|Drug: Fluticasone Furoate Inhalation Powder|Drug: Placebo Inhaltion Powder
URL: http://ClinicalTrials.gov/show/NCT01165138
Étude 64:
Titre: Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control
Recruitment: Completed
Study Results: Has Results
Conditions: Diabetes Mellitus, Type 2
Interventions: Drug: linagliptin|Drug: placebo
URL: http://ClinicalTrials.gov/show/NCT00621140
Étude 65:
Titre: Safety and Efficacy Extension Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Sclérose en plaques, Relapsing-Remitting
Interventions: Drug: Daclizumab HYP|Drug: Daclizumab HYP
URL: http://ClinicalTrials.gov/show/NCT00870740
Étude 66:
Titre: Phase III Acute Coronary Syndrome
Recruitment: Terminated
Study Results: No Results Available
Conditions: Acute Coronary Syndrome
Interventions: Drug: Apixaban|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT00831441
Étude 67:
Titre: The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Recruitment: Terminated
Study Results: No Results Available
Conditions: Breast Neoplasms|Neoplasms, Hormone-Dependent
Interventions: Drug: Atamestane|Drug: Toremifene|Drug: Letrozole|Drug: Aromatase inhibition|Drug: Estrogen receptor blocker|Procédure: Hormone therapy|Procédure: Endocrine therapy|Procédure: Antiestrogen therapy
URL: http://ClinicalTrials.gov/show/NCT00097344
Étude 68:
Titre: Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily
Recruitment: Completed
Study Results: No Results Available
Conditions: Asthma
Interventions: Drug: Fluticasone Propionate 100mcg BD|Drug: GSK2190915 100mg|Drug: GSK2190915 10mg|Drug: GSK2190915 300mg|Drug: GSK2190915 30mg|Drug: Montelukast 10mg|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT01147744
Étude 69:
Titre: Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin’s Lymphoma
Recruitment: Completed
Study Results: Has Results
Conditions: Non-Hodgkin’s Lymphoma
Interventions: Drug: Bortezomib + Rituximab|Drug: Rituximab
URL: http://ClinicalTrials.gov/show/NCT00312845
Étude 70:
Titre: TroVax Renal Immunotherapy Survival Trial
Recruitment: Completed
Study Results: No Results Available
Conditions: Clear Cell Renal Carcinoma
Interventions: Biological: Trovax
URL: http://ClinicalTrials.gov/show/NCT00397345
Étude 71:
Titre: PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease
Recruitment: Completed
Study Results: No Results Available
Conditions: Coronary Artery Disease (CAD)
Interventions: Drug: A-002
URL: http://ClinicalTrials.gov/show/NCT00455546
Étude 72:
Titre: VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Acute Coronary Syndrome
Interventions: Drug: A-002, varespladib methyl|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT01130246
Étude 73:
Titre: Eslicarbazepine Acetate Monotherapy Long Term Study
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Epilepsy
Interventions: Drug: Eslicarbazepine acetate
URL: http://ClinicalTrials.gov/show/NCT00910247
Étude 74:
Titre: Effectiveness and Safety of Flexible Doses of Paliperidone Prolonged Release in Adolescent Patients With Schizophrenia
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Schizophrenia
Interventions: Drug: Aripiprazole|Drug: Paliperidone PR
URL: http://ClinicalTrials.gov/show/NCT01009047
Étude 75:
Titre: Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients
Recruitment: Completed
Study Results: No Results Available
Conditions: Venous Thromboembolism
Interventions: Drug: Xarelto (Rivaroxaban, BAY59-7939)|Drug: Enoxaparin
URL: http://ClinicalTrials.gov/show/NCT00571649
Étude 76:
Titre: Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Metastatic Pancreatic Cancer
Interventions: Drug: Albumin-bound paclitaxel (ABI-007)/Gemcitabine|Drug: Gemcitabine
URL: http://ClinicalTrials.gov/show/NCT00844649
Étude 77:
Titre: Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing Remitting Multiple Sclerosis
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Sclérose en plaques, Relapsing-Remitting
Interventions: Drug: Daclizumab HYP
URL: http://ClinicalTrials.gov/show/NCT01051349
Étude 78:
Titre: GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis
Recruitment: Completed
Study Results: No Results Available
Conditions: Rheumatoid Arthritis
Interventions: Drug: GLPG0259 oral capsule|Drug: Placebo|Drug: GLPG0259 (Part B)|Drug: Placebo (Part B)
URL: http://ClinicalTrials.gov/show/NCT01211249
Étude 79:
Titre: A Study of First-line Maintenance Tarceva (Erlotinib) Versus Tarceva at Time of Disease Progression in Patients With Advanced Non-small Cell Lung Cancer After Chemotherapy
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Non-Small Cell Lung Cancer
Interventions: Drug: erlotinib [Tarceva]|Drug: Placebo|Drug: erlotinib [Tarceva]
URL: http://ClinicalTrials.gov/show/NCT01328951
Étude 80:
Titre: Comparison of Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Type 1 Diabetes Mellitus
Interventions: Drug: Technosphere® Insulin with Gen2 Inhaler|Drug: Insulin aspart, basal insulin|Drug: Technosphere® Insulin with MedTone C Inhaler
URL: http://ClinicalTrials.gov/show/NCT01445951
Étude 81:
Titre: Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Peripheral Arterial Occlusive Disease
Interventions: Drug: Alprostadil|Other: Placebo
URL: http://ClinicalTrials.gov/show/NCT00596752
Étude 82:
Titre: 26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension
Recruitment: Completed
Study Results: Has Results
Conditions: Hypertension
Interventions: Drug: fixed-dose combination of telmisartan 40mg+amlodipine 10mg|Drug: fixed-dose combination of telmisartan 80mg+amlodipine10mg
URL: http://ClinicalTrials.gov/show/NCT00624052
Étude 83:
Titre: The Purpose of the Study is to Determine Whether Cariprazine is a Safe and Tolerated Long-term Treatment in Patients With Chronic Stable Schizophrenia
Recruitment: Completed
Study Results: No Results Available
Conditions: Schizophrenia
Interventions: Drug: Cariprazine
URL: http://ClinicalTrials.gov/show/NCT00839852
Étude 84:
Titre: Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
Recruitment: Completed
Study Results: Has Results
Conditions: Thrombosis, Venous|Superficial Thrombophlebitis
Interventions: Drug: Fondaparinux 2.5mg or placebo
URL: http://ClinicalTrials.gov/show/NCT00443053
Étude 85:
Titre: A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Schizoaffective Disorder
Interventions: Drug: Placebo|Drug: paliperidone palmitate
URL: http://ClinicalTrials.gov/show/NCT01193153
Étude 86:
Titre: A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation
Recruitment: Completed
Study Results: No Results Available
Conditions: Atrial Fibrillation|Thromboembolism
Interventions: Drug: Edoxaban (DU-176b)|Drug: Edoxaban (DU-176b)|Drug: Edoxaban (DU-176b)|Drug: Edoxaban (DU-176b)|Drug: warfarin
URL: http://ClinicalTrials.gov/show/NCT00504556
Étude 87:
Titre: Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa
Recruitment: Completed
Study Results: No Results Available
Conditions: Acne Vulgaris
Interventions: Drug: Valette|Drug: Diane|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT00280657
Étude 88:
Titre: Lurasidone – A 24-week Extension Study of Patients With Bipolar I Depression
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Bipolar|Depression
Interventions: Drug: lurasidone
URL: http://ClinicalTrials.gov/show/NCT00868959
Étude 89:
Titre: PRoFESS – Prevention Regimen For Effectively Avoiding Second Strokes
Recruitment: Completed
Study Results: Has Results
Conditions: Cerebrovascular Accident
Interventions: Drug: extended-release dipyridamole + aspirin|Drug: clopidogrel|Drug: telmisartan
URL: http://ClinicalTrials.gov/show/NCT00153062
Étude 90:
Titre: Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension
Recruitment: Completed
Study Results: Has Results
Conditions: Hypertension
Interventions: Drug: amlodipine|Drug: telmisartan|Drug: telmisartan and amlodipine
URL: http://ClinicalTrials.gov/show/NCT00860262
Étude 91:
Titre: Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Epilepsy
Interventions: Drug: Eslicarbazepine acetate 1600 mg|Drug: Eslicarbazepine acetate 1200 mg
URL: http://ClinicalTrials.gov/show/NCT01091662
Étude 92:
Titre: Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Myocardial Infarction|Cardiovascular Death|Atherothrombosis|Accident vasculaire cérébral
Interventions: Drug: Ticagrelor 90 mg|Drug: Ticagrelor 60 mg|Drug: Ticagrelor Placebo
URL: http://ClinicalTrials.gov/show/NCT01225562
Étude 93:
Titre: Study of Combination Thalidomide Plus Glucocorticoid Therapy Versus Glucocorticoid Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Multiple Myeloma
Interventions: Drug: Thalidomide and Dexamethasone|Drug: Dexamethasone
URL: http://ClinicalTrials.gov/show/NCT00057564
Étude 94:
Titre: Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Leukaemia, Lymphocytic, Chronic|Chronic Lymphocytic Leukemia
Interventions: Drug: OFC Infusion|Drug: FC infusion
URL: http://ClinicalTrials.gov/show/NCT00824265
Étude 95:
Titre: A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
Recruitment: Completed
Study Results: No Results Available
Conditions: Cystic Fibrosis
Interventions: Drug: tobramycin|Drug: tobramycin
URL: http://ClinicalTrials.gov/show/NCT00885365
Étude 96:
Titre: Safety and Efficacy of Cariprazine in Patients With Schizophrenia
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Schizophrenia
Interventions: Drug: Cariprazine|Drug: Cariprazine|Drug: Aripiprazole|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT01104766
Étude 97:
Titre: Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension
Recruitment: Completed
Study Results: Has Results
Conditions: Hypertension
Interventions: Drug: fixed dose combination of telmisartan+amlodipine|Drug: amlodipine
URL: http://ClinicalTrials.gov/show/NCT00553267
Étude 98:
Titre: Fenofibrate and Metformin Fixed Combination vs Rosiglitazone – FAME ROSI
Recruitment: Terminated
Study Results: No Results Available
Conditions: Dyslipidemia|Glucose Metabolism Disorder
Interventions: Drug: fenofibrate (F) + metformin (M) hydrochloride fixed combination|Drug: Rosiglitazone
URL: http://ClinicalTrials.gov/show/NCT00361868
Étude 99:
Titre: Safety and Efficacy of Cariprazine for Bipolar I Disorder
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Mania|Bipolar I Disorder
Interventions: Drug: Cariprazine low dose|Drug: Cariprazine high dose|Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT01058668
Étude 100:
Titre: A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Atrial Fibrillation
Interventions: Drug: Apixaban|Drug: Acetylsalicylic Acid (ASA)|Drug: Apixaban
URL: http://ClinicalTrials.gov/show/NCT00496769
